• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Diabetic Ketoacidosis in a Pediatric Patient with Cystic Fibrosis-related Diabetes.一名患有囊性纤维化相关糖尿病的儿科患者的糖尿病酮症酸中毒
JCEM Case Rep. 2025 May 21;3(7):luaf114. doi: 10.1210/jcemcr/luaf114. eCollection 2025 Jul.
2
Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).针对具有 II 类 CFTR 基因突变(最常见的是 F508del)的囊性纤维化患者的校正治疗(含或不含增效剂)。
Cochrane Database Syst Rev. 2020 Dec 17;12(12):CD010966. doi: 10.1002/14651858.CD010966.pub3.
3
Combined CFTR modulator therapies are linked with anabolic benefits and insulin-sparing in cystic fibrosis-related diabetes.联合CFTR调节剂疗法与囊性纤维化相关糖尿病的合成代谢益处和胰岛素节省作用相关。
J Clin Transl Endocrinol. 2023 Jun 24;33:100320. doi: 10.1016/j.jcte.2023.100320. eCollection 2023 Sep.
4
Clinical efficacy of elexacaftor-tezacaftor-ivacaftor in an adolescent with homozygous G85E cystic fibrosis.依列卡福妥-替扎卡福妥-依伐卡托对一名纯合子G85E囊性纤维化青少年患者的临床疗效
Respir Med Case Rep. 2022 Nov 7;40:101775. doi: 10.1016/j.rmcr.2022.101775. eCollection 2022.
5
Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).针对携带 II 类 CFTR 基因突变(最常见的是 F508del)的囊性纤维化患者的校正治疗(有或没有增效剂)。
Cochrane Database Syst Rev. 2023 Nov 20;11(11):CD010966. doi: 10.1002/14651858.CD010966.pub4.
6
Decline in HbA1c during the first year of elexacaftor/tezacaftor/ivacaftor treatment in the Danish cystic fibrosis cohort: Short title: Decline in HbA1c after elexacaftor/tezacaftor/ivacaftor treatment.依利尤单抗治疗中国特发性肺纤维化患者的疗效和安全性:一项多中心、随机、双盲、安慰剂对照的 III 期临床研究
J Cyst Fibros. 2024 Jan;23(1):103-108. doi: 10.1016/j.jcf.2023.11.005. Epub 2023 Nov 21.
7
The effect of elexacaftor/tezacaftor/ivacaftor (ETI) on glycemia in adults with cystic fibrosis.依利卓(elexacaftor/tezacaftor/ivacaftor,ETI)对成年囊性纤维化患者血糖的影响。
J Cyst Fibros. 2022 Mar;21(2):258-263. doi: 10.1016/j.jcf.2021.09.001. Epub 2021 Sep 14.
8
Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.连续血糖监测和晚期糖基化终产物预测成人 CF 相关糖尿病的临床结局和发展。
Front Endocrinol (Lausanne). 2024 Feb 6;15:1293709. doi: 10.3389/fendo.2024.1293709. eCollection 2024.
9
The Effects of Elexacaftor, Tezacaftor, and Ivacaftor (ETI) on Blood Glucose in Patients With Cystic Fibrosis: A Systematic Review.依列卡福妥、替扎卡福妥和依伐卡托(ETI)对囊性纤维化患者血糖的影响:一项系统评价。
Cureus. 2023 Jul 11;15(7):e41697. doi: 10.7759/cureus.41697. eCollection 2023 Jul.
10
Effect of CFTR modulator therapy on cystic fibrosis-related diabetes.囊性纤维化相关糖尿病的 CFTR 调节剂治疗效果。
J Diabetes Complications. 2021 Jun;35(6):107845. doi: 10.1016/j.jdiacomp.2020.107845. Epub 2021 Jan 5.

本文引用的文献

1
Advances in diabetes technology to improve the lives of people with cystic fibrosis.糖尿病技术的进步改善了囊性纤维化患者的生活。
Diabetologia. 2024 Oct;67(10):2143-2153. doi: 10.1007/s00125-024-06223-3. Epub 2024 Jul 12.
2
An Update in Cystic Fibrosis-Related Diabetes in Children and Adolescents.儿童和青少年囊性纤维化相关糖尿病的最新进展
Children (Basel). 2023 Nov 30;10(12):1879. doi: 10.3390/children10121879.
3
Advances in cystic fibrosis-related diabetes: Current status and future directions.囊性纤维化相关糖尿病的进展:现状与未来方向。
Diabetes Metab Syndr. 2023 Nov;17(11):102899. doi: 10.1016/j.dsx.2023.102899. Epub 2023 Nov 2.
4
Diabetic ketoacidosis as a unique initial presentation of cystic fibrosis.糖尿病酮症酸中毒作为囊性纤维化的一种独特初始表现。
Diabet Med. 2022 Nov;39(11):e14859. doi: 10.1111/dme.14859. Epub 2022 May 5.
5
Risk factors for hospitalization in youth with type 1 diabetes: Development and validation of a multivariable prediction model.1 型糖尿病青少年住院的风险因素:多变量预测模型的建立和验证。
Pediatr Diabetes. 2020 Nov;21(7):1268-1276. doi: 10.1111/pedi.13090. Epub 2020 Aug 28.
6
ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state.《国际儿童和青少年糖尿病学会(ISPAD)2018年临床实践共识指南:糖尿病酮症酸中毒和高血糖高渗状态》
Pediatr Diabetes. 2018 Oct;19 Suppl 27:155-177. doi: 10.1111/pedi.12701.
7
Development of insulin antibodies and changes in titers over a long-term period in patients with type 2 diabetes.2型糖尿病患者胰岛素抗体的产生及长期内滴度的变化。
Clin Chim Acta. 2014 Jun 10;433:135-8. doi: 10.1016/j.cca.2014.03.008. Epub 2014 Mar 16.
8
Low morbidity and mortality in children with diabetic ketoacidosis treated with isotonic fluids.儿童糖尿病酮症酸中毒经等渗液治疗,发病率和死亡率低。
J Pediatr. 2013 Sep;163(3):761-6. doi: 10.1016/j.jpeds.2013.02.005. Epub 2013 Mar 15.
9
Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society.囊性纤维化相关糖尿病临床护理指南:美国糖尿病协会立场声明及囊性纤维化基金会临床实践指南,获儿科内分泌学会认可。
Diabetes Care. 2010 Dec;33(12):2697-708. doi: 10.2337/dc10-1768.
10
Diabetic keto-acidosis as a presentation of cystic fibrosis-related diabetes: a case report.糖尿病酮症酸中毒为囊性纤维化相关性糖尿病的表现:病例报告。
J Diabetes Complications. 2011 Mar-Apr;25(2):137-41. doi: 10.1016/j.jdiacomp.2010.05.003. Epub 2010 Jul 24.

一名患有囊性纤维化相关糖尿病的儿科患者的糖尿病酮症酸中毒

Diabetic Ketoacidosis in a Pediatric Patient with Cystic Fibrosis-related Diabetes.

作者信息

Harinarayanan Shyam, Merritt Taylor, White Perrin C

机构信息

Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX 75390-9063, USA.

出版信息

JCEM Case Rep. 2025 May 21;3(7):luaf114. doi: 10.1210/jcemcr/luaf114. eCollection 2025 Jul.

DOI:10.1210/jcemcr/luaf114
PMID:40401175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12093047/
Abstract

Cystic fibrosis (CF), a genetic disorder caused by pathogenic variants in the gene, is associated with various complications including cystic fibrosis-related diabetes (CFRD). CFRD is an entity distinct from type 1 or type 2 diabetes. We report a rare case of diabetic ketoacidosis (DKA) in a pediatric patient with CFRD, occurring during a significant pulmonary exacerbation. The patient's management involved addressing fluid and electrolyte imbalances, careful monitoring of nutritional status, and correction of hyperglycemia with insulin. This case serves as a reminder to consider DKA in the differential diagnosis of patients with CF presenting with respiratory distress, even in the absence of typical symptoms such as polyuria and polydipsia.

摘要

囊性纤维化(CF)是一种由该基因的致病变异引起的遗传性疾病,与包括囊性纤维化相关糖尿病(CFRD)在内的各种并发症相关。CFRD是一种有别于1型或2型糖尿病的疾病。我们报告了一例患有CFRD的儿科患者发生糖尿病酮症酸中毒(DKA)的罕见病例,该病例发生在严重的肺部病情加重期间。对该患者的治疗包括纠正液体和电解质失衡、仔细监测营养状况以及用胰岛素纠正高血糖。该病例提醒我们,即使在没有多尿和多饮等典型症状的情况下,对于出现呼吸窘迫的CF患者进行鉴别诊断时也要考虑到DKA。